Gufic Biosciences Ltd (BOM:509079)
₹ 405.65 5.4 (1.35%) Market Cap: 40.68 Bil Enterprise Value: 44.00 Bil PE Ratio: 46.68 PB Ratio: 7.64 GF Score: 93/100

Q3 2022 Gufic Biosciences Ltd Earnings Call Transcript

Feb 10, 2022 / 11:00AM GMT
Release Date Price: ₹228.2 (-3.83%)
Operator

Ladies and gentlemen, good day, and welcome to the Gufic Biosciences Limited Q3 FY21-22 earnings conference call. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Ms. Ami Shah, Company Secretary. Thank you, and over to you, ma'am.

Ami Shah
Gufic Biosciences Limited - Company Secretary

Good evening, everyone. I am Ami Shah, Secretary of Gufic Biosciences Limited. I welcome you all to Q3 FY2021-2022 earning conference call. I have with me Mr. Pranav Choksi, Chief Executive Officer, and Whole time Director; Mr. Devkinandan B Roonghta, Chief Financial Officer; and Mr. Avik Das from Investor Relations team to give the highlights of the business performance of the company and to clarify the queries of the investors during the call.

After the opening remarks from the management, operator will open the bridge for Q&A session. But before we proceed with the call, please note some of the statement made in today's discussion may be forward-looking and are based on management's current expectation,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot